il18 signaling in vivo (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
93
Structured Review
MedChemExpress
il18 signaling in vivo
Il18 Signaling In Vivo, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il18+signaling+in+vivo/IL-18%2C+Mouse/pm37041059-94-8-16
Average 93 stars, based on 1 article reviews
Il18 Signaling In Vivo, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il18+signaling+in+vivo/IL-18%2C+Mouse/pm37041059-94-8-16
Average 93 stars, based on 1 article reviews
il18 signaling in vivo - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
In Vivo:Article Title: NET-Triggered NLRP3 Activation and IL18 Release Drive Oxaliplatin-Induced Peripheral Neuropathy. Article Snippet: To validate that the components DNAandRNAofNETs contribute to the development of OIPN, mice were injected with DNase1 (D5025, Sigma; 150 U, i.v.) from the first day of modeling to the 14th day or from the sixth day ofmodeling to the 14th day.Mice were injectedwith RNase1 (DNase, protease-free, Thermo Fisher, EN0531; 1 mg/kg, i.v.) from the first day of modeling to the 14th day or from the sixth day of modeling to the 14th day. .. To verify the ability of IL18BP to inhibit Article Title: NET-Triggered NLRP3 Activation and IL18 Release Drive Oxaliplatin-Induced Peripheral Neuropathy Article Snippet: Mice were injected with RNase1 (DNase, protease-free, Thermo Fisher, EN0531; 1 mg/kg, i.v.) from the first day of modeling to the 14th day or from the sixth day of modeling to the 14th day. .. To verify the ability of IL18BP to inhibit Recombinant:Article Title: NET-Triggered NLRP3 Activation and IL18 Release Drive Oxaliplatin-Induced Peripheral Neuropathy. Article Snippet: To validate that the components DNAandRNAofNETs contribute to the development of OIPN, mice were injected with DNase1 (D5025, Sigma; 150 U, i.v.) from the first day of modeling to the 14th day or from the sixth day ofmodeling to the 14th day.Mice were injectedwith RNase1 (DNase, protease-free, Thermo Fisher, EN0531; 1 mg/kg, i.v.) from the first day of modeling to the 14th day or from the sixth day of modeling to the 14th day. .. To verify the ability of IL18BP to inhibit Article Title: NET-Triggered NLRP3 Activation and IL18 Release Drive Oxaliplatin-Induced Peripheral Neuropathy Article Snippet: Mice were injected with RNase1 (DNase, protease-free, Thermo Fisher, EN0531; 1 mg/kg, i.v.) from the first day of modeling to the 14th day or from the sixth day of modeling to the 14th day. .. To verify the ability of IL18BP to inhibit |